SUBSCRIBE
SUBSCRIBE
News   Deals

Japan’s Astellas Pharma Inc. to Buy U.S. Agensys, Inc. for $387 Million

November 27, 2007 | 
1 min read
TOKYO, Nov 27 (Reuters) - Japanese drugmaker Astellas Pharma Inc (4503.T: Quote, Profile, Research) said on Tuesday it would buy U.S. biotech company Agensys Inc for $387 million to boost its antibody research and development for cancer treatments.
Mergers & acquisitions Asia
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
March 6, 2026
 · 
1 min read
 · 
Annalee Armstrong
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Cardiovascular disease
Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets
March 5, 2026
 · 
2 min read
 · 
Heather McKenzie
Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.
Collaboration
Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge
March 5, 2026
 · 
1 min read
 · 
Tristan Manalac
Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.
Funding
Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac